Crane Company CR
Composite 60/100; the shares have moved about 35% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 31/100 — a moderate mark against it.
Balance-sheet strength ranks 80/100 — a strong point in its favour. Growth ranks 73/100 — a moderate point in its favour. Quality ranks 64/100 — a moderate point in its favour.
Valuation ranks 31/100 — a moderate mark against it. Income ranks 40/100 — a slight mark against it.
What the company does Crane Company (CR) designs and manufactures engineered industrial products across Aerospace & Advanced Technologies and Process Flow Technologies. Aerospace supplies critical components for commercial, military, defense, and space markets, while Process Flow provides valves, pumps, and related systems for industrial applications.
Key financials CR posts strong gross margins (44.6%) and operating margins (24.8%), with ROE at 16.6% and ROA at 9.0%. Revenue grew 24.9% but EPS fell -37.8%. Debt/Equity is 0.50, interest coverage 18.76, and current ratio 2.80, indicating solid liquidity.
Stock health Momentum is positive over 3m (21.64%), 6m (17.82%), and 12m (8.53%), though -7.08% below its 52-week high. Sideravia scores CR 54.5 overall, with Strength at 80.7 and Valuation at 22.7, reflecting average quality and rich valuation.
Price vs fair value CR trades at a PREMIUM of 55.30% to our fair-value estimate of 95.74 and a discount of 7.80% to the analyst 12-month target of 230.89. - Q2 2026 earnings call highlighted record sales growth and raised EPS guidance (GuruFocus.com, MarketBeat). - StockStory noted acquisitions and aerospace momentum driving results (StockStory). - Simply Wall St. called Q2 results strong but noted a mixed first half.
Looking forward Forward P/E of 33.56 and PEG of 1.42 suggest high expectations are priced in. Analysts see potential upside to 230.89, but valuation remains stretched relative to fair value. Focus remains on aerospace momentum and execution in Process Flow.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.